• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DAS28、SDAI和CDAI的可视化:类风湿关节炎的神奇毯。

Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis.

作者信息

Futó Gábor, Somogyi Attila, Szekanecz Zoltán

机构信息

Department of Rheumatology, Institute of Medicine, University of Debrecen Medical and Health Science Center, Nagyerdei str 98, Debrecen, 4032, Hungary.

出版信息

Clin Rheumatol. 2014 May;33(5):623-9. doi: 10.1007/s10067-014-2559-5. Epub 2014 Mar 6.

DOI:10.1007/s10067-014-2559-5
PMID:24599677
Abstract

There has been continuous debate regarding the applicability of various composite measures for the assessment of disease activity in rheumatoid arthritis (RA). In order to further dissect this issue, we numerically and graphically modeled 28-joint disease activity scale (DAS28), simplified disease activity index (SDAI), and clinical disease activity index (CDAI) by three-dimensional (3D) plotting. We wished to graphically visualize the relative contribution of various elements in the three activity indices to each other. We calculated DAS28 (3 variables), SDAI, and CDAI by the standard equations. We plotted 3D "carpets" showing all combinations of the corresponding variables yielding to DAS28 = 5.1, DAS28 = 3.2, DAS28 = 2.6, SDAI = 26, SDAI = 11, and SDAI = 3.3. We also plotted the 3D carpet for CDAI. In patients with high or moderate disease activity, erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) was not a major confounding factor when calculating DAS28 and SDAI, respectively. In contrast, ESR and CRP highly overshadowed changes in joint counts and global assessments in patients with low disease activity (LDA) or those in remission. No reliable assessment of LDA can be performed in cases where ESR >54 mm/h or CRP >20 mg/dl. Similarly, remission cannot be determined if ESR >19 mm/h or CRP >5 mg/dl. As CDAI does not include acute phase reactants, CDAI may be a useful tool even in states of remission or LDA. Our results suggest that acute phase reactants are indeed major confounding factors and should be omitted when assessing RA disease activity at least in special cases.

摘要

关于各种综合指标在类风湿关节炎(RA)疾病活动度评估中的适用性一直存在持续的争论。为了进一步剖析这个问题,我们通过三维(3D)绘图对28关节疾病活动度量表(DAS28)、简化疾病活动指数(SDAI)和临床疾病活动指数(CDAI)进行了数值和图形建模。我们希望以图形方式直观呈现这三个活动指数中各要素之间的相对贡献。我们根据标准方程计算DAS28(3个变量)、SDAI和CDAI。我们绘制了3D“地毯图”,展示了对应变量的所有组合,这些组合分别得出DAS28 = 5.1、DAS28 = 3.2、DAS28 = 2.6、SDAI = 26、SDAI = 11和SDAI = 3.3。我们还绘制了CDAI的3D地毯图。在疾病活动度高或中度的患者中,计算DAS28和SDAI时,红细胞沉降率(ESR)或C反应蛋白(CRP)分别不是主要的混杂因素。相比之下,在疾病活动度低(LDA)或缓解期的患者中,ESR和CRP极大地掩盖了关节计数和整体评估的变化。当ESR > 54 mm/h或CRP > 20 mg/dl时,无法对LDA进行可靠评估。同样,如果ESR > 19 mm/h或CRP > 5 mg/dl,则无法确定缓解状态。由于CDAI不包括急性期反应物,即使在缓解期或LDA状态下,CDAI也可能是一个有用的工具。我们的结果表明,急性期反应物确实是主要的混杂因素,至少在特殊情况下评估RA疾病活动度时应予以忽略。

相似文献

1
Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis.DAS28、SDAI和CDAI的可视化:类风湿关节炎的神奇毯。
Clin Rheumatol. 2014 May;33(5):623-9. doi: 10.1007/s10067-014-2559-5. Epub 2014 Mar 6.
2
How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?与简化疾病活动指数相比,28 关节红细胞沉降率和 C 反应蛋白计算的疾病活动评分低估了多少疾病活动?
Ann Rheum Dis. 2015 Jun;74(6):1132-7. doi: 10.1136/annrheumdis-2013-204920. Epub 2014 Aug 20.
3
Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.托珠单抗抑制白细胞介素-6受体与类风湿关节炎疾病缓解的实现:急性期反应物的作用
Arthritis Rheum. 2011 Jan;63(1):43-52. doi: 10.1002/art.27740.
4
Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.类风湿关节炎患者达到 DAS、SDAI 或 CDAI 缓解但未达到布尔缓解时疾病活动度测量的差异。
Semin Arthritis Rheum. 2020 Apr;50(2):276-284. doi: 10.1016/j.semarthrit.2019.09.005. Epub 2019 Sep 19.
5
Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.临床疾病活动指数(CDAI)和简化疾病活动指数(SDAI)在评估类风湿性关节炎患者时的表现似乎优于金标准疾病评估评分(DAS-28-CRP)。
Int J Rheum Dis. 2018 Nov;21(11):1933-1939. doi: 10.1111/1756-185X.13110. Epub 2017 Jun 12.
6
Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints.类风湿关节炎基于患者对压痛和肿胀关节的自我评估时,疾病活动评分 28 个 C 反应蛋白(DAS28-CRP)、简化疾病活动指数(SDAI)和临床疾病活动指数(CDAI)的重测信度。
Clin Rheumatol. 2013 Oct;32(10):1493-500. doi: 10.1007/s10067-013-2300-9. Epub 2013 Jun 11.
7
DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.DAS28、CDAI 和 SDAI 切点不能翻译相同的信息:来自葡萄牙风湿病登记处 Reuma.pt 的结果。
Rheumatology (Oxford). 2015 Feb;54(2):286-91. doi: 10.1093/rheumatology/keu313. Epub 2014 Aug 29.
8
American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.美国风湿病学会/欧洲抗风湿病联盟的类风湿关节炎缓解标准在评估 44 个关节时具有可靠的性能。
J Rheumatol. 2013 Aug;40(8):1254-8. doi: 10.3899/jrheum.130166. Epub 2013 Jun 15.
9
[Comparison of four assessment criteria for disease activity of rheumatoid arthritis].[类风湿关节炎疾病活动度的四种评估标准比较]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Mar;46(2):280-4.
10
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.急性期反应物对类风湿关节炎综合疾病活动指数的贡献不大:一种临床活动评分的验证
Arthritis Res Ther. 2005;7(4):R796-806. doi: 10.1186/ar1740. Epub 2005 Apr 7.

引用本文的文献

1
A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis.一项关于不同综合测量方法(疾病活动评分28、临床疾病活动指数、简化疾病活动指数和布尔运算方法)在确定类风湿关节炎低疾病活动度和缓解期治疗效果方面的系统比较。
BMC Rheumatol. 2022 Dec 9;6(1):82. doi: 10.1186/s41927-022-00314-7.
2
Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage.类风湿关节炎患者对白细胞介素 6 阻断剂的反应中循环单核细胞-血小板结合物的增加。
Int J Mol Sci. 2022 May 20;23(10):5748. doi: 10.3390/ijms23105748.
3

本文引用的文献

1
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.EULAR 推荐的治疗类风湿关节炎的合成和生物疾病修饰抗风湿药物:2013 更新版。
Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25.
2
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.类风湿关节炎的关节损伤在缓解期会根据28个关节的疾病活动评分进展,且由残留的肿胀关节驱动。
Arthritis Rheum. 2011 Dec;63(12):3702-11. doi: 10.1002/art.30634.
3
CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis.
CCR2/CCL2和CMKLR1/RvE1趋化因子系统水平与类风湿性关节炎中的胰岛素抵抗相关。
PLoS One. 2021 Jan 28;16(1):e0246054. doi: 10.1371/journal.pone.0246054. eCollection 2021.
4
Smartphone Data in Rheumatoid Arthritis - What Do Rheumatologists Want?类风湿关节炎中的智能手机数据——风湿病学家想要什么?
AMIA Annu Symp Proc. 2015 Nov 5;2015:1130-9. eCollection 2015.
5
Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment.优化类风湿关节炎治疗:利用疾病活动度的客观指标指导治疗。
Am Health Drug Benefits. 2015 Oct;8(7):354-60.
Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI.
评估类风湿关节炎的疾病活动度:哪种综合指数最佳?比较 DAS、DAS28、SDAI 和 CDAI 心理测量特性的系统文献分析。
Joint Bone Spine. 2012 Mar;79(2):149-55. doi: 10.1016/j.jbspin.2011.04.008. Epub 2011 Jun 15.
4
Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.托珠单抗抑制白细胞介素-6受体与类风湿关节炎疾病缓解的实现:急性期反应物的作用
Arthritis Rheum. 2011 Jan;63(1):43-52. doi: 10.1002/art.27740.
5
A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.用于流行病学研究的无急性期反应物的改良类风湿关节炎疾病活动评分(mDAS28)。
J Rheumatol. 2010 Aug 1;37(8):1607-14. doi: 10.3899/jrheum.090831. Epub 2010 Jul 1.
6
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.EULAR 推荐的使用合成和生物疾病修饰抗风湿药物治疗类风湿关节炎的建议。
Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5.
7
Treating rheumatoid arthritis to target: recommendations of an international task force.靶向治疗类风湿关节炎:国际工作组的建议。
Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9.
8
Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).类风湿关节炎日常实践中的疾病活动度评估:包括28个关节的疾病活动评分(DAS28)与临床疾病活动指数(CDAI)相比的效度、内部一致性、信度和一致性
Clin Exp Rheumatol. 2009 Jul-Aug;27(4):552-9.
9
Comparison of three rheumatoid arthritis disease activity scores in clinical routine.三种类风湿关节炎疾病活动评分在临床常规中的比较。
Scand J Rheumatol. 2009;38(5):336-41. doi: 10.1080/03009740902932835.
10
Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data.评估类风湿关节炎疾病活动度的不同方法:阿巴西普临床试验数据分析
Ann Rheum Dis. 2009 Apr;68(4):484-9. doi: 10.1136/ard.2008.092577. Epub 2008 Dec 11.